Tuberculosis Reactivation Risk in Patients Treated with Tumor Necrosis Factor Alpha Inhibitors: A Turkish Experience with Higher Mortality and Different Background Diseases.

Kisacik, BunyaminPamuk, OmerOnat, Ahmet MesutErer, B.Hatemi, GulenOzguler, YesimPehlivan, Yavuz2024-06-122024-06-1220142326-51912326-5205https://hdl.handle.net/20.500.14551/2680678th Annual Meeting of the American-College-of-Rheumatology (ACR) / 49th Meeting of the Association-of-Rheumatology-Health-Professionals (ARHP) -- NOV 14-19, 2014 -- Boston, MA[Abstract Not Available]eninfo:eu-repo/semantics/closedAccess[No Keywords]Tuberculosis Reactivation Risk in Patients Treated with Tumor Necrosis Factor Alpha Inhibitors: A Turkish Experience with Higher Mortality and Different Background Diseases.Conference Object66S943S943Q4WOS:000344384904305